Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
-
Published:2024-04
Issue:
Volume:70
Page:102517
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Wannigama Dhammika LeshanORCID, Hurst Cameron, Phattharapornjaroen Phatthranit, Hongsing Parichart, Sirichumroonwit Natchalaikorn, Chanpiwat Kanokpoj, Rad S.M. Ali Hosseini, Storer Robin James, Ounjai Puey, Kanthawee Phitsanuruk, Ngamwongsatit NatharinORCID, Kupwiwat Rosalyn, Kupwiwat Chaisit, Brimson James MichaelORCID, Devanga Ragupathi Naveen Kumar, Charuluxananan Somrat, Leelahavanichkul Asada, Kanjanabuch Talerngsak, Higgins Paul G.ORCID, Badavath Vishnu NayakORCID, Amarasiri MohanORCID, Verhasselt Valerie, Kicic AnthonyORCID, Chatsuwan Tanittha, Pirzada Kashif, Jalali Farid, Reiersen Angela M.ORCID, Abe Shuichi, Ishikawa Hitoshi, Tanasatitchai Chanikan, Amphol Supamat, Nantawong Ladda, Sangchan Prangrawee, Sinkajarern Varissara, Phoonakh Thutpharritchn, Utenpattanun Phornnapat, Sithu Shein Aye Mya, Vitoonpong Timporn, Chongthavonsatit Nichapha, Mankong Yahya, Chaichana Piyapong, Yaithet Jenjira, Pongprajak Dumrongsak, Traimuangpak Sukjai, Saksirisampant Gasit, Lamloeskittinon Phimonsiri, Hamdy Adam Adam, Kosasih Sinthu Sinthu, Luk-in Sirirat Sirirat
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|